Advanced Portfolio Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-6,540
Closed -$1M 99
2023
Q1
$1M Buy
+6,540
New +$1.08M 1% 36

Other funds holding MRNA

Advanced Portfolio Management's MRNA Position: Q1 2024 in Review

Advanced Portfolio Management sold out of Moderna (MRNA) in Q1 2024, closing a stake of 6,014 shares — an estimated $598K sold.

Advanced Portfolio Management first reported a position in MRNA in Q4 2023 and held it in 1 quarter. The position peaked at $598K in Q4 2023. 902 funds tracked by Wall St. Rank hold MRNA as of Q1 2024.

  • Advanced Portfolio Management reported no remaining Moderna position as of Q1 2024 after selling out during the quarter.
  • Advanced Portfolio Management sold 6,014 Moderna shares in Q1 2024, an estimated $598K.
  • Advanced Portfolio Management first reported a position in Moderna in Q4 2023 and held it in 1 quarter.
  • Advanced Portfolio Management's Moderna position peaked at $598K in Q4 2023.
  • 902 funds tracked by Wall St. Rank held Moderna as of Q1 2024.

Based on Advanced Portfolio Management's 13F filing for Q1 2024, filed 15 May 2024.